https://trialagents.com/ weekly 1.0 https://trialagents.com/reports daily 0.8 https://trialagents.com/reports?page=2 weekly 0.6 https://trialagents.com/reports?page=3 weekly 0.6 https://trialagents.com/reports?page=4 weekly 0.6 https://trialagents.com/reports?page=5 weekly 0.6 https://trialagents.com/reports?page=6 weekly 0.6 https://trialagents.com/reports?page=7 weekly 0.6 https://trialagents.com/reports?page=8 weekly 0.6 https://trialagents.com/reports?page=9 weekly 0.6 https://trialagents.com/reports?page=10 weekly 0.6 https://trialagents.com/reports?page=11 weekly 0.6 https://trialagents.com/reports?page=12 weekly 0.6 https://trialagents.com/reports?page=13 weekly 0.6 https://trialagents.com/reports?page=14 weekly 0.6 https://trialagents.com/reports?page=15 weekly 0.6 https://trialagents.com/reports?page=16 weekly 0.6 https://trialagents.com/reports/top-eu-rna-phase-1-2-trial-sites 2026-07-30T12:06:30.632Z weekly 0.7 https://trialagents.com/reports/europe-respiratory-phase-2-3-endpoints 2026-07-30T12:06:30.584Z weekly 0.7 https://trialagents.com/reports/top-eu-nephrology-phase-2-3-sites 2026-07-30T12:06:30.534Z weekly 0.7 https://trialagents.com/reports/eu-colorectal-phase-2-3-endpoints 2026-07-30T12:06:30.486Z weekly 0.7 https://trialagents.com/reports/eu-oncology-phase-iii-cro-demand 2026-07-30T12:06:30.433Z weekly 0.7 https://trialagents.com/reports/phase-i-haematology-ctis-timing-drivers 2026-07-30T12:06:30.388Z weekly 0.7 https://trialagents.com/reports/top-eu-ibd-phase-2-3-trial-sites 2026-07-30T12:06:30.334Z weekly 0.7 https://trialagents.com/reports/obesity-phase-2-3-europe-cro-demand 2026-07-30T12:06:30.295Z weekly 0.7 https://trialagents.com/reports/europe-hcc-phase-2-3-cro-demand 2026-07-30T12:06:30.248Z weekly 0.7 https://trialagents.com/reports/eu-ovarian-phase-2-3-endpoints 2026-07-30T12:06:30.209Z weekly 0.7 https://trialagents.com/reports/colorectal-phase-2-3-cro-europe 2026-07-30T12:06:30.161Z weekly 0.7 https://trialagents.com/reports/lung-cancer-phase-iii-os-endpoint-patterns 2026-07-30T12:06:30.123Z weekly 0.7 https://trialagents.com/reports/top-eu-depression-phase-ii-iii-trial-sites 2026-07-30T12:06:30.080Z weekly 0.7 https://trialagents.com/reports/phase-i-respiratory-ctis-timing-drivers 2026-07-30T12:06:30.042Z weekly 0.7 https://trialagents.com/reports/phase-ii-gastroenterology-ctis-drivers 2026-07-30T12:06:30.001Z weekly 0.7 https://trialagents.com/reports/cro-use-lung-cancer-trials-europe 2026-07-30T12:06:29.959Z weekly 0.7 https://trialagents.com/reports/phase-1-neurology-ctis-review-times-factors 2026-07-30T12:06:29.911Z weekly 0.7 https://trialagents.com/reports/top-eu-gene-therapy-phase-1-3-sites 2026-07-30T12:06:29.846Z weekly 0.7 https://trialagents.com/reports/kidney-cancer-phase-iii-os-vs-pfs-endpoints 2026-07-30T12:06:29.798Z weekly 0.7 https://trialagents.com/reports/eu-phase-1-gastroenterology-ctis-review-times 2026-07-30T12:06:29.746Z weekly 0.7 https://trialagents.com/reports/eu-lupus-phase-2-3-trial-endpoints 2026-07-30T12:06:29.701Z weekly 0.7 https://trialagents.com/reports/top-eu-multiple-myeloma-phase-ii-iii-sites 2026-07-30T12:06:29.663Z weekly 0.7 https://trialagents.com/reports/phase-ii-cardiology-ctis-timing-drivers 2026-07-30T12:06:29.612Z weekly 0.7 https://trialagents.com/reports/eu-cardiology-phase-3-cro-outsourcing 2026-07-30T12:06:29.565Z weekly 0.7 https://trialagents.com/reports/pediatric-phase-3-europe-cro-use 2026-07-30T12:06:29.522Z weekly 0.7 https://trialagents.com/reports/eu-cell-therapy-phase-1-3-cro-outsourcing 2026-07-30T12:06:29.484Z weekly 0.7 https://trialagents.com/reports/phase-iii-cell-therapy-ctis-timing-drivers 2026-07-30T12:06:29.441Z weekly 0.7 https://trialagents.com/reports/phase-i-nephrology-ctis-timing-drivers 2026-07-30T12:06:29.403Z weekly 0.7 https://trialagents.com/reports/digital-recruitment-in-phase-iii-upper-gi-trials 2026-07-30T12:06:29.332Z weekly 0.7 https://trialagents.com/reports/eu-cardiology-phase-2-3-endpoints 2026-07-30T12:06:29.295Z weekly 0.7 https://trialagents.com/reports/eu-endocrinology-phase-3-cro-demand 2026-07-30T12:06:29.248Z weekly 0.7 https://trialagents.com/reports/lymphoma-phase-iii-pfs-vs-os-endpoints 2026-07-30T12:06:29.205Z weekly 0.7 https://trialagents.com/reports/pancreatic-cancer-europe-phase-2-3-cro-demand 2026-07-30T12:06:29.157Z weekly 0.7 https://trialagents.com/reports/endometrial-cancer-phase-2-3-europe-cro-demand 2026-07-30T12:06:29.110Z weekly 0.7 https://trialagents.com/reports/eu-hcc-phase-2-3-trial-endpoints 2026-07-30T12:06:29.068Z weekly 0.7 https://trialagents.com/reports/cro-use-european-breast-cancer-trials-2024-2026 2026-07-30T12:06:29.024Z weekly 0.7 https://trialagents.com/reports/eu-breast-cancer-phase-ii-iii-endpoints 2026-07-30T12:06:28.973Z weekly 0.7 https://trialagents.com/reports/head-neck-cancer-phase-2-3-europe-cros 2026-07-30T12:06:28.933Z weekly 0.7 https://trialagents.com/reports/phase-ii-pediatric-ctis-timing-drivers 2026-07-30T12:06:28.877Z weekly 0.7 https://trialagents.com/reports/eu-pancreatic-phase-2-3-endpoints 2026-07-30T12:06:28.840Z weekly 0.7 https://trialagents.com/reports/pancreatic-phase-iii-os-and-pfs-patterns 2026-07-30T12:06:28.797Z weekly 0.7 https://trialagents.com/reports/phase-ii-nephrology-ctis-timing-drivers 2026-07-30T12:06:28.757Z weekly 0.7 https://trialagents.com/reports/eu-endometrial-uterine-phase-2-3-endpoints 2026-07-30T12:06:28.710Z weekly 0.7 https://trialagents.com/reports/ckd-phase-2-3-europe-cro-outsourcing 2026-07-30T12:06:28.667Z weekly 0.7 https://trialagents.com/reports/eu-rcc-phase-2-3-endpoint-patterns 2026-07-30T12:06:28.619Z weekly 0.7 https://trialagents.com/reports/eu-dermatology-phase-2-3-endpoints 2026-07-30T12:06:28.578Z weekly 0.7 https://trialagents.com/reports/phase-3-oncology-efficacy-endpoints 2026-07-30T12:06:28.525Z weekly 0.7 https://trialagents.com/reports/eu-depression-mdd-phase-2-3-endpoints 2026-07-30T12:06:28.482Z weekly 0.7 https://trialagents.com/reports/top-eu-haematology-phase-3-trial-sites 2026-07-30T12:06:28.434Z weekly 0.7 https://trialagents.com/reports/top-eu-vaccine-phase-1-3-trial-sites 2026-07-30T12:06:28.394Z weekly 0.7 https://trialagents.com/reports/phase-ii-oncology-ctis-timing-drivers 2026-07-30T12:06:28.340Z weekly 0.7 https://trialagents.com/reports/phase-i-oncology-ctis-review-times-delay-factors 2026-07-30T12:06:28.295Z weekly 0.7 https://trialagents.com/reports/phase-iii-paediatric-ctis-timing-drivers 2026-07-30T12:06:28.251Z weekly 0.7 https://trialagents.com/reports/adc-phase-1-3-europe-cro-demand 2026-07-30T12:06:28.214Z weekly 0.7 https://trialagents.com/reports/glioblastoma-glioma-eu-cro-trial-support 2026-07-30T12:06:28.166Z weekly 0.7 https://trialagents.com/reports/phase-2-cell-therapy-eu-ctis-timelines 2026-07-30T12:06:28.128Z weekly 0.7 https://trialagents.com/reports/top-eu-diabetes-phase-ii-iii-trial-sites 2026-07-30T12:06:28.073Z weekly 0.7 https://trialagents.com/reports/top-eu-immunology-phase-3-trial-sites 2026-07-30T12:06:28.034Z weekly 0.7 https://trialagents.com/reports/os-and-pfs-use-in-phase-iii-oncology 2026-07-30T12:06:27.988Z weekly 0.7 https://trialagents.com/reports/phase-ii-infectious-disease-ctis-timelines 2026-07-30T12:06:27.945Z weekly 0.7 https://trialagents.com/reports/phase-i-rare-disease-ctis-timing-drivers 2026-07-30T12:06:27.896Z weekly 0.7 https://trialagents.com/reports/eu-immunology-phase-iii-cro-demand 2026-07-30T12:06:27.857Z weekly 0.7 https://trialagents.com/reports/eu-phase-2-haematology-ctis-review-times-delay 2026-07-30T12:06:27.808Z weekly 0.7 https://trialagents.com/reports/alzheimers-europe-phase-2-3-cro-demand 2026-07-30T12:06:27.756Z weekly 0.7 https://trialagents.com/reports/eu-lung-cancer-phase-2-3-endpoints 2026-07-30T12:06:27.705Z weekly 0.7 https://trialagents.com/reports/eu-infectious-disease-phase-3-cro-demand 2026-07-30T12:06:27.662Z weekly 0.7 https://trialagents.com/reports/top-eu-prostate-phase-ii-iii-trial-sites 2026-07-30T12:06:27.618Z weekly 0.7 https://trialagents.com/reports/colorectal-phase-iii-os-vs-pfs-endpoints 2026-07-30T12:06:27.578Z weekly 0.7 https://trialagents.com/reports/oncology-phase-iii-endpoint-architecture 2026-07-30T12:06:27.529Z weekly 0.7 https://trialagents.com/reports/top-eu-phase-iii-cell-therapy-trial-sites 2026-07-30T12:06:27.479Z weekly 0.7 https://trialagents.com/reports/phase-3-rare-disease-ctis-timelines-factors 2026-07-30T12:06:27.418Z weekly 0.7 https://trialagents.com/reports/eu-leukemia-phase-ii-iii-endpoints 2026-07-30T12:06:27.368Z weekly 0.7 https://trialagents.com/reports/gene-therapy-phase-1-3-europe-cro-capacity 2026-07-30T12:06:27.313Z weekly 0.7 https://trialagents.com/reports/efs-oncology-trials-2024-2026 2026-07-30T12:06:27.158Z weekly 0.7 https://trialagents.com/reports/top-eu-kidney-cancer-phase-ii-iii-sites 2026-07-30T12:06:27.043Z weekly 0.7 https://trialagents.com/reports/ovarian-phase-2-3-europe-cro-usage 2026-07-30T12:06:26.990Z weekly 0.7 https://trialagents.com/reports/top-eu-bladder-cancer-phase-ii-iii-sites 2026-07-30T12:06:26.936Z weekly 0.7 https://trialagents.com/reports/depression-phase-2-3-europe-cro-demand 2026-07-30T12:06:26.870Z weekly 0.7 https://trialagents.com/reports/eu-infectious-disease-phase-3-sites 2026-07-30T12:06:26.814Z weekly 0.7 https://trialagents.com/reports/eu-psoriasis-psa-phase-2-3-endpoints 2026-07-30T12:06:26.776Z weekly 0.7 https://trialagents.com/reports/phase-3-haematology-ctis-timelines-delay 2026-07-30T12:06:26.717Z weekly 0.7 https://trialagents.com/reports/bladder-urothelial-phase-2-3-europe-cro-demand 2026-07-30T12:06:26.678Z weekly 0.7 https://trialagents.com/reports/eu-diabetes-phase-2-3-endpoints 2026-07-30T12:06:26.630Z weekly 0.7 https://trialagents.com/reports/adc-phase-2-3-eu-trial-sites 2026-07-30T12:06:26.592Z weekly 0.7 https://trialagents.com/reports/melanoma-phase-2-3-europe-cro-capacity 2026-07-30T12:06:26.544Z weekly 0.7 https://trialagents.com/reports/phase-i-infectious-disease-ctis-timelines 2026-07-30T12:06:26.503Z weekly 0.7 https://trialagents.com/reports/breast-cancer-phase-iii-eligibility-patterns 2026-07-30T12:06:26.464Z weekly 0.7 https://trialagents.com/reports/eu-infectious-disease-phase-2-3-endpoints 2026-07-30T12:06:26.427Z weekly 0.7 https://trialagents.com/reports/eu-myeloma-phase-2-3-endpoints 2026-07-30T12:06:26.377Z weekly 0.7 https://trialagents.com/reports/eu-ckd-kidney-failure-phase-2-3-endpoints 2026-07-30T12:06:26.338Z weekly 0.7 https://trialagents.com/reports/orphan-phase-3-europe-cro-outsourcing 2026-07-30T12:06:26.281Z weekly 0.7 https://trialagents.com/reports/top-eu-rna-phase-3-trial-sites 2026-07-30T12:06:26.221Z weekly 0.7 https://trialagents.com/reports/europe-ophthalmology-phase-2-and-3-cros 2026-07-30T12:06:26.143Z weekly 0.7 https://trialagents.com/reports/phase-3-lung-cancer-trial-design-europe 2026-07-30T12:06:16.502Z weekly 0.7 https://trialagents.com/reports/vaccine-phase-1-3-europe-cro-demand 2026-07-30T12:06:16.462Z weekly 0.7 https://trialagents.com/reports/phase-ii-neurology-ctis-timing-drivers 2026-07-30T12:06:16.424Z weekly 0.7 https://trialagents.com/reports/phase-iii-gene-therapy-ctis-timing-drivers 2026-07-30T12:06:16.387Z weekly 0.7 https://trialagents.com/reports/phase-i-pediatric-ctis-timing-drivers 2026-07-30T12:06:16.349Z weekly 0.7 https://trialagents.com/reports/top-eu-paediatric-phase-3-trial-sites 2026-07-30T12:06:16.283Z weekly 0.7 https://trialagents.com/reports/leukemia-phase-2-3-europe-cro-outsourcing 2026-07-30T12:06:16.244Z weekly 0.7 https://trialagents.com/reports/phase-3-neurology-ctis-review-times-delay-factors 2026-07-30T12:06:16.193Z weekly 0.7 https://trialagents.com/reports/eu-obesity-phase-ii-iii-endpoint-patterns 2026-07-30T12:06:16.155Z weekly 0.7 https://trialagents.com/reports/phase-ii-rare-disease-ctis-timelines-delay 2026-07-30T12:06:16.103Z weekly 0.7 https://trialagents.com/reports/eu-alzheimers-phase-2-3-endpoints 2026-07-30T12:06:16.064Z weekly 0.7 https://trialagents.com/reports/phase-iii-cardiology-ctis-timing-drivers 2026-07-30T12:06:16.011Z weekly 0.7 https://trialagents.com/reports/eu-phase-3-gastroenterology-ctis-timelines 2026-07-30T12:06:15.973Z weekly 0.7 https://trialagents.com/reports/phase-iii-nephrology-ctis-timing-drivers 2026-07-30T12:06:15.929Z weekly 0.7 https://trialagents.com/reports/rare-disease-phase-iii-cro-demand-europe 2026-07-30T12:06:15.892Z weekly 0.7 https://trialagents.com/reports/eu-neurology-phase-2-3-endpoint-patterns 2026-07-30T12:06:15.844Z weekly 0.7 https://trialagents.com/reports/breast-cancer-phase-iii-endpoint-architecture 2026-07-30T12:06:15.803Z weekly 0.7 https://trialagents.com/reports/top-eu-upper-gi-phase-ii-iii-trial-sites 2026-07-30T12:06:15.756Z weekly 0.7 https://trialagents.com/reports/gastric-esophageal-eu-phase-2-3-endpoints 2026-07-30T12:06:15.719Z weekly 0.7 https://trialagents.com/reports/haematology-phase-3-europe-cro-demand 2026-07-30T12:06:15.672Z weekly 0.7 https://trialagents.com/reports/phase-ii-respiratory-ctis-timing-drivers 2026-07-30T12:06:15.634Z weekly 0.7 https://trialagents.com/reports/top-eu-gastric-phase-2-and-3-trial-sites 2026-07-30T12:06:15.583Z weekly 0.7 https://trialagents.com/reports/ctis-phase-1-immunology-review-times-factors 2026-07-30T12:06:15.544Z weekly 0.7 https://trialagents.com/reports/top-european-phase-iii-psychiatry-trial-sites 2026-07-30T12:06:15.507Z weekly 0.7 https://trialagents.com/reports/os-as-a-phase-iii-oncology-endpoint-anchor 2026-07-30T12:06:15.470Z weekly 0.7 https://trialagents.com/reports/pfs-primary-endpoints-in-phase-iii-oncology 2026-07-30T12:06:15.424Z weekly 0.7 https://trialagents.com/reports/top-eu-glioblastoma-glioma-phase-1-3-sites 2026-07-30T12:06:15.385Z weekly 0.7 https://trialagents.com/reports/rcc-phase-2-3-europe-cro-activity 2026-07-30T12:06:15.346Z weekly 0.7 https://trialagents.com/reports/eu-ckd-phase-ii-iii-trial-site-networks 2026-07-30T12:06:15.302Z weekly 0.7 https://trialagents.com/reports/eu-hnscc-phase-2-3-endpoints 2026-07-30T12:06:15.257Z weekly 0.7 https://trialagents.com/reports/top-eu-phase-iii-dermatology-trial-sites 2026-07-30T12:06:15.219Z weekly 0.7 https://trialagents.com/reports/top-eu-phase-ii-cell-therapy-trial-sites 2026-07-30T12:06:15.176Z weekly 0.7 https://trialagents.com/reports/top-eu-radiopharmaceutical-phase-1-3-sites 2026-07-30T12:06:15.131Z weekly 0.7 https://trialagents.com/reports/top-eu-ophthalmology-phase-2-3-trial-sites 2026-07-30T12:06:15.069Z weekly 0.7 https://trialagents.com/reports/prostate-phase-2-3-europe-cro-complexity 2026-07-30T12:06:15.030Z weekly 0.7 https://trialagents.com/reports/digital-recruitment-in-phase-iii-breast-trials 2026-07-30T12:06:14.990Z weekly 0.7 https://trialagents.com/reports/eu-mds-phase-2-3-trial-endpoints 2026-07-30T12:06:14.953Z weekly 0.7 https://trialagents.com/reports/eu-ibd-phase-2-3-trial-endpoints 2026-07-30T12:06:14.908Z weekly 0.7 https://trialagents.com/reports/eu-glioma-phase-2-3-endpoints 2026-07-30T12:06:14.858Z weekly 0.7 https://trialagents.com/reports/top-eu-melanoma-phase-ii-iii-trial-sites 2026-07-30T12:06:14.805Z weekly 0.7 https://trialagents.com/reports/top-eu-lymphoma-phase-ii-iii-trial-sites 2026-07-30T12:06:14.769Z weekly 0.7 https://trialagents.com/reports/eu-neurology-phase-3-cro-demand 2026-07-30T12:06:14.725Z weekly 0.7 https://trialagents.com/reports/ctis-cardiology-phase-1-review-times-delay-drivers 2026-07-30T12:06:14.687Z weekly 0.7 https://trialagents.com/reports/top-eu-ibd-phase-ii-iii-trial-sites 2026-07-30T12:06:14.641Z weekly 0.7 https://trialagents.com/reports/dermatology-phase-3-europe-cro-demand 2026-07-30T12:06:14.602Z weekly 0.7 https://trialagents.com/reports/psychiatry-phase-2-3-cro-europe 2026-07-30T12:06:14.565Z weekly 0.7 https://trialagents.com/reports/top-eu-heart-failure-phase-3-trial-sites 2026-07-30T12:06:14.521Z weekly 0.7 https://trialagents.com/reports/ctis-infectious-disease-phase-3-review-times 2026-07-30T12:06:14.478Z weekly 0.7 https://trialagents.com/reports/eu-mds-phase-2-3-cro-demand 2026-07-30T12:06:14.440Z weekly 0.7 https://trialagents.com/reports/phase-3-oncology-ctis-timelines-delay-factors 2026-07-30T12:06:14.385Z weekly 0.7 https://trialagents.com/reports/eu-heart-failure-phase-2-3-endpoints 2026-07-30T12:06:14.347Z weekly 0.7 https://trialagents.com/reports/eu-endocrinology-phase-2-3-endpoints 2026-07-30T12:06:14.302Z weekly 0.7 https://trialagents.com/reports/top-cros-eu-phase-3-lung-cancer-trials 2026-07-30T12:06:14.263Z weekly 0.7 https://trialagents.com/reports/eu-ms-phase-2-3-endpoint-patterns 2026-07-30T12:06:14.226Z weekly 0.7 https://trialagents.com/reports/eu-ra-phase-ii-iii-endpoints 2026-07-30T12:06:14.188Z weekly 0.7 https://trialagents.com/reports/eu-nephrology-phase-2-3-endpoints 2026-07-30T12:06:14.144Z weekly 0.7 https://trialagents.com/reports/top-eu-phase-i-cell-therapy-trial-sites 2026-07-30T12:06:14.107Z weekly 0.7 https://trialagents.com/reports/top-eu-endometrial-cancer-trial-sites 2026-07-30T12:06:14.059Z weekly 0.7 https://trialagents.com/reports/diabetes-phase-2-3-europe-cro-demand 2026-07-30T12:06:14.019Z weekly 0.7 https://trialagents.com/reports/top-eu-ovarian-cancer-phase-ii-iii-sites 2026-07-30T12:06:13.980Z weekly 0.7 https://trialagents.com/reports/eu-lymphoma-phase-2-3-endpoints 2026-07-30T12:06:13.942Z weekly 0.7 https://trialagents.com/reports/top-eu-cardiology-phase-ii-iii-trial-sites 2026-07-30T12:06:13.898Z weekly 0.7 https://trialagents.com/reports/top-eu-alzheimers-phase-ii-iii-trial-sites 2026-07-30T12:06:13.855Z weekly 0.7 https://trialagents.com/reports/top-eu-hnscc-phase-1-3-trial-sites 2026-07-30T12:06:13.807Z weekly 0.7 https://trialagents.com/reports/eu-heart-failure-phase-2-3-cro-outsourcing 2026-07-30T12:06:13.759Z weekly 0.7 https://trialagents.com/reports/gastric-phase-iii-os-endpoint-patterns 2026-07-30T12:06:13.718Z weekly 0.7 https://trialagents.com/reports/eu-gastro-phase-2-3-endpoints 2026-07-30T12:06:13.682Z weekly 0.7 https://trialagents.com/reports/phase-1-cell-therapy-ctis-timelines-factors 2026-07-30T12:06:13.629Z weekly 0.7 https://trialagents.com/reports/multiple-myeloma-eu-phase-2-3-cro-support 2026-07-30T12:06:13.587Z weekly 0.7 https://trialagents.com/reports/eu-haematology-phase-2-3-endpoints 2026-07-30T12:06:13.534Z weekly 0.7 https://trialagents.com/reports/eu-radiopharmaceutical-phase-1-3-cro-demand 2026-07-30T12:06:13.493Z weekly 0.7 https://trialagents.com/reports/lymphoma-phase-2-3-europe-cro-use 2026-07-30T12:06:13.454Z weekly 0.7 https://trialagents.com/reports/eu-gastric-esophageal-phase-2-3-cros 2026-07-30T12:06:13.416Z weekly 0.7 https://trialagents.com/reports/europe-melanoma-phase-2-3-endpoints 2026-07-30T12:06:13.369Z weekly 0.7 https://trialagents.com/reports/eu-respiratory-phase-3-cro-demand 2026-07-30T12:06:13.322Z weekly 0.7 https://trialagents.com/reports/psoriasis-psoriatic-arthritis-europe-cro-demand 2026-07-30T12:06:13.266Z weekly 0.7 https://trialagents.com/reports/ctis-eu-phase-2-immunology-timelines-factors 2026-07-30T12:06:13.225Z weekly 0.7 https://trialagents.com/reports/eu-nephrology-phase-ii-iii-cro-demand 2026-07-30T12:06:13.170Z weekly 0.7 https://trialagents.com/reports/ibd-phase-2-3-europe-cro-use 2026-07-30T12:06:13.131Z weekly 0.7 https://trialagents.com/reports/phase-i-gene-therapy-ctis-timing-drivers 2026-07-30T12:06:13.085Z weekly 0.7 https://trialagents.com/reports/eu-psychiatry-phase-2-3-trial-endpoints 2026-07-30T12:06:13.043Z weekly 0.7 https://trialagents.com/reports/europe-lupus-phase-2-3-cro-outsourcing 2026-07-30T12:06:13.005Z weekly 0.7 https://trialagents.com/reports/europe-ra-phase-2-3-cro-activity 2026-07-30T12:06:12.966Z weekly 0.7 https://trialagents.com/reports/eu-bladder-urothelial-phase2-3-endpoints 2026-07-30T12:06:12.902Z weekly 0.7 https://trialagents.com/reports/eu-phase-3-respiratory-ctis-timelines-factors 2026-07-30T12:06:12.861Z weekly 0.7 https://trialagents.com/reports/eu-ms-phase-2-3-cro-activity 2026-07-30T12:06:12.801Z weekly 0.7 https://trialagents.com/reports/eu-psoriasis-phase-ii-iii-trial-sites 2026-07-30T12:06:12.763Z weekly 0.7 https://trialagents.com/reports/eu-ophthalmology-phase-ii-iii-endpoints 2026-07-30T12:06:12.714Z weekly 0.7 https://trialagents.com/reports/top-eu-leukemia-phase-ii-iii-trial-sites 2026-07-30T12:06:12.674Z weekly 0.7 https://trialagents.com/reports/eu-gastroenterology-phase-3-cro-demand 2026-07-30T12:06:12.629Z weekly 0.7 https://trialagents.com/reports/phase-iii-immunology-ctis-timing-drivers 2026-07-30T12:06:12.566Z weekly 0.7 https://trialagents.com/reports/eu-liver-cancer-phase-ii-iii-trial-sites 2026-07-30T12:06:12.502Z weekly 0.7 https://trialagents.com/reports/eu-colorectal-phase-ii-iii-trial-sites 2026-07-30T12:06:12.453Z weekly 0.7 https://trialagents.com/reports/eu-prostate-phase-2-3-endpoints 2026-07-30T12:06:12.254Z weekly 0.7